EDN1 and endothelial dysfunction: Pravastatin significantly reduced the secretion of both ET-1 and sFlt-1 (key mediators of endothelial dysfunction) in primary human umbilical vein endothelial cells (HUVECs) and uterine microvascular cells (UtMVs) (19).